Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr Moncef Slaoui, PhD, to its Board of Directors. A highly ...

They are not given to making sanctimonious claims that they wake up every morning to save the world — as their companies ...

GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline ... Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

After initially focusing on hoses, it has expanded to develop products from other waste products like parachute silk, shoe boxes, coffee sacks and auction banners. Stocked in 10 countries ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other undervalued defensive Stocks for 2025. The consumer defensive sector covers products that everyone ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

The Genshin Impact 5.4 Banner and event details have been officially announced for the latest patch, titled Moonlight Amidst Dreams. In the fourth update since Natlan's debut, we're returning to ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...